Boule Diagnostics AB (publ)

Stockholm Stock Exchange:BOUL.ST

Location

Market Cap

USD 37.38 M

Share Price

USD 0.69

Avg Daily Volume

65,717

Change (1 day)

0.76%

Change (1 year)

-14.52%

Change (YTD)

-15.24%

Boule Diagnostics AB (publ) EBITDA Margin for the year ending December 31, 2024: -45.81%

Boule Diagnostics AB (publ) EBITDA Margin is -45.81% for the year ending December 31, 2024, a -496.69% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Boule Diagnostics AB (publ) EBITDA Margin for the year ending December 31, 2023 was 11.55%, a 9.42% change year over year.
  • Boule Diagnostics AB (publ) EBITDA Margin for the year ending December 31, 2022 was 10.55%, a -12.20% change year over year.
  • Boule Diagnostics AB (publ) EBITDA Margin for the year ending December 31, 2021 was 12.02%, a 183.51% change year over year.
  • Boule Diagnostics AB (publ) EBITDA Margin for the year ending December 31, 2020 was 4.24%, a -77.25% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin